Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Applicants Under the Generic Drug User Fee Act (draft guidance)
Insights
Dive Into Our Latest s
Product-Specific Guidance Meetings Between the Food and Drug Administration and Abbreviated New Drug Applicants Under the Generic Drug User Fee Act (draft guidance)
By ClinChoice
June 28, 2024
SHARE
Let's Build a Healthier
& Safer World, Together
Connect with ClinChoice to discover how we can support the
development and commercialization of your drug or device.